Lateral flow urine lipoarabinomannan assay

An international review team has prepared a Cochrane systematic review to assess the accuracy of a point-of-care urine test for diagnosing and screening tuberculosis (TB) in people living with human immunodeficiency virus (HIV). This review looks at accuracy of the lateral flow urine lipoarabinomannan assay (LF-LAM), a commercially available test that detects lipoarabinomannan (LAM), a component of mycobacterial cell walls, which is present in some people with active TB. The test is simple to carry out, requires no special equipment and provides a result within 25 minutes. The draft of this systematic review informed the WHO policy recommendations on the use of LF-LAM for the diagnosis and screening of active TB in people living with HIV (WHO Lipoarabinomannan Policy Guidance 2015).
Source : www.medicalnewstoday.com      2016/5/24 13:03

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
0/10 (تعداد آرا 0 نفر )
Copyright © 2011 AASM. All Rights Reserved.